Two new international research projects at the Ocular Surface Laboratory are testing the effectiveness and safety of commercially available treatments from Alcon’s Systane range for dry eye symptoms and discomfort due to contact lens (CL)-related dryness.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
